Skip to main content
NIH funding notice PA-16-252

Gene Fusions in Pediatric Sarcomas (R21)

Closed on May 7, 2019.

Posted
May 10, 2016
Close date
May 7, 2019
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

8 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,650,989 in first-year total cost, median $199,665.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 MCT2-C (01)]2
  2. Cancer Biomarkers Study Section[CBSS]1
  3. Cancer Genetics Study Section[CG]1
  4. Cancer Molecular Pathobiology Study Section[CAMP]1
  5. Developmental Therapeutics Study Section[DT]1

Most frequent institutions

  1. COLD SPRING HARBOR LABORATORY1
  2. GEORGETOWN UNIVERSITY1
  3. OREGON HEALTH & SCIENCE UNIVERSITY1
  4. RESEARCH INST NATIONWIDE CHILDREN'S HOSP1
  5. ROSWELL PARK CANCER INSTITUTE CORP1
Competing awards under PA-16-252 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Elucidating the function of PAX3-FOXO1 in rhabdomyosarcoma with molecular reporters and next-generation genome editing1R21CA245859-01VAKOC, CHRISTOPHERCOLD SPRING HARBOR LABORATORY, NY$269,280CG
2020Screening small molecules for rhabdomyosarcoma fusion proteins1R21CA220087-01A1UREN, AYKUTGEORGETOWN UNIVERSITY, DC$181,741DMP
2019Drug susceptibilities in fusion oncogene-driven pediatric sarcomas1R21CA235092-01A1GELMAN, IRWIN H.ROSWELL PARK CANCER INSTITUTE CORP, NY$227,984ZRG1
2019Oncogenic fusion gene FAX-FKHR in driving metabolic reprogramming in alveolar rhabdomyosarcoma1R21CA227926-01A1CHANDLER, DAWN SWANG, RUONINGRESEARCH INST NATIONWIDE CHILDREN'S HOSP, OH$198,360TCB
2019Ewing sarcoma: fusion protein structure/function relationships that reprogram transcription1R21CA238499-01SCHWARTZ, JACOB C.UNIVERSITY OF ARIZONA, AZ$192,138CAMP
2019Targeting EWS-FLI1 protein stability as therapeutic strategy for Ewing sarcoma1R21CA234979-01A1DAVIS, IAN JLIU, PENGDAUNIV OF NORTH CAROLINA CHAPEL HILL, NC$169,106ZRG1
2018Metabolic Profiling in Pediatric Fusion Positive Sarcoma1R21CA220090-01A1LEAVEY, PATRICK JOSEPHUT SOUTHWESTERN MEDICAL CENTER, TX$211,410CBSS
2017Targeting EWS-ATF1 in CCSST1R21CA220061-01XIAO, XIANGSHUOREGON HEALTH & SCIENCE UNIVERSITY, OR$200,970DT

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PA-16-252: Gene Fusions in Pediatric Sarcomas (R21) | ScienceDex | ConductScience